These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds. De Clercq E; Descamps J; Ogata M; Shigeta S Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207 [TBL] [Abstract][Full Text] [Related]
6. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. De Clercq E Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377 [TBL] [Abstract][Full Text] [Related]
7. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism. De C; Liu D; Zheng B; Singh US; Chavre S; White C; Arnold RD; Hagen FK; Chu CK; Moffat JF Antiviral Res; 2014 Oct; 110():10-9. PubMed ID: 25051026 [TBL] [Abstract][Full Text] [Related]
8. Oral BVDU treatment of varicella and zoster in children with cancer. Benoit Y; Laureys G; Delbeke MJ; De Clercq E Eur J Pediatr; 1985 Jan; 143(3):198-202. PubMed ID: 3987714 [TBL] [Abstract][Full Text] [Related]
9. Molecular biology of varicella-zoster virus. A review prepared for the UK Advisory Group on Chickenpox. Harper DR; Gilbert RL; Jeffries DJ J Infect; 1998 Jan; 36 Suppl 1():1-10. PubMed ID: 9514102 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine. De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386 [TBL] [Abstract][Full Text] [Related]
12. Baculovirus replication: inhibition of Trichoplusia ni multiple nuclear polyhedrosis virus by [E]-5-(2-bromovinyl)-2'-deoxyuridine. Wang X; Lescott T; De Clercq E; Kelly DC J Gen Virol; 1983 Jun; 64 (Pt 6)():1221-7. PubMed ID: 6343553 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629 [TBL] [Abstract][Full Text] [Related]
14. Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy. Ida M; Kageyama S; Sato H; Kamiyama T; Toyomoto T; Ozaki T; Kajita Y; Morohashi M; Shiraki K J Dermatol Sci; 2000 May; 23(1):63-72. PubMed ID: 10699766 [TBL] [Abstract][Full Text] [Related]
15. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? Andrei G; De Clercq E; Snoeck R Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799 [TBL] [Abstract][Full Text] [Related]
16. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet. Bleymehl K; Cinatl J; Schmidt-Chanasit J Med Microbiol Immunol; 2011 Aug; 200(3):193-202. PubMed ID: 21373931 [TBL] [Abstract][Full Text] [Related]
18. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. Lacey SF; Suzutani T; Powell KL; Purifoy DJ; Honess RW J Gen Virol; 1991 Mar; 72 ( Pt 3)():623-30. PubMed ID: 1848597 [TBL] [Abstract][Full Text] [Related]
19. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Sakuma T Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298 [TBL] [Abstract][Full Text] [Related]
20. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Morfin F; Frobert E; Thouvenot D Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]